Back
Novo Nordisk A/S Vs. NovoCure Ltd. Industry Stock Comparison
Sell
46
NVO
Novo Nordisk A/S
Last Price:
$57.45
Seasonality Move:
3.8%
Sell
33
NVCR
NovoCure Ltd.
Last Price:
$14.88
Seasonality Move:
-7.29%
Sell
46
Novo Nordisk A/S (NVO)
is a Sell
Is Novo Nordisk A/S a Buy, Sell or Hold?
-
The current Novo Nordisk A/S [NVO] share price is $56.57. The Score for NVO is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
-
NVO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
33
NovoCure Ltd. (NVCR)
is a Sell
Is NovoCure Ltd. a Buy, Sell or Hold?
-
The current NovoCure Ltd. [NVCR] share price is $14.41. The Score for NVCR is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
-
NVCR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NVO Stock Price Chart
What is Novo Nordisk A/S's stock price today?
-
The Novo Nordisk A/S share price today is $56.57Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NVO is experiencing selling pressure, which indicates risk of future bearish movement.
NVCR Stock Price Chart
What is NovoCure Ltd.'s stock price today?
-
The NovoCure Ltd. share price today is $14.41Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NVCR is experiencing slight selling pressure.
NVO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.59 | Buy |
| Relative Strength Index (14 RSI): | 70.97 | Buy |
| Chaikin Money Flow: | -9768965 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (47.38 - 53) | Buy |
| Bollinger Bands (100): | (48.69 - 57.19) | Buy |
NVCR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.41 | Buy |
| Relative Strength Index (14 RSI): | 66.22 | Buy |
| Chaikin Money Flow: | -161853 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (12.08 - 13.72) | Buy |
| Bollinger Bands (100): | (11.81 - 13.65) | Buy |
NVO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 53.29 | Buy |
| 20-day SMA: | 50.86 | Buy |
| 50-day SMA: | 49.4 | Buy |
| 200-day SMA: | 59.43 | Sell |
| 8-day EMA: | 53.77 | Buy |
| 20-day EMA: | 51.66 | Buy |
| 50-day EMA: | 51.16 | Buy |
| 200-day EMA: | 62.01 | Sell |
NVCR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 13.6 | Buy |
| 20-day SMA: | 13.21 | Buy |
| 50-day SMA: | 12.51 | Buy |
| 200-day SMA: | 14.66 | Sell |
| 8-day EMA: | 13.7 | Buy |
| 20-day EMA: | 13.23 | Buy |
| 50-day EMA: | 12.91 | Buy |
| 200-day EMA: | 14.76 | Sell |
Novo Nordisk A/S Earnings Growth & NVO Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.45 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.18 per share, and an increase next year of $0.37 per share.
NovoCure Ltd. Earnings Growth & NVCR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.10 per share, and an increase next year of $0.40 per share.
Novo Nordisk A/S Technical Analysis
| Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 2 | Jan 5 | Jan 6 | Jan 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 23 | 24 | 26 | 29 | 30 | 31 | 02 | 05 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
NovoCure Ltd. Technical Analysis
| Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 5 | Jan 6 | Jan 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 22 | 23 | 24 | 26 | 29 | 30 | 31 | 05 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||